Porrata Luis F
Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, Minnesota.
J Clin Apher. 2018 Jun;33(3):324-330. doi: 10.1002/jca.21611. Epub 2017 Dec 12.
In addition to stem cells, T-cells, natural killer cells, dendritic cells, and monocytes are also collected and infused from the autograft in patients undergoing autologous peripheral blood hematopoietic stem cell transplantation. Recent reports have shown that these autograft immune effector cells can affect the clinical outcome postautologous peripheral blood hematopoietic stem cell transplantation. In this article, I will review the clinical impact on the survival of these autograft immune effector cells conferring the concept of autologous graft versus tumor effect.
除了干细胞外,T细胞、自然杀伤细胞、树突状细胞和单核细胞也从接受自体外周血造血干细胞移植的患者的自体移植物中采集并回输。最近的报告显示,这些自体移植物免疫效应细胞可影响自体外周血造血干细胞移植后的临床结局。在本文中,我将综述这些自体移植物免疫效应细胞对生存的临床影响,从而引出自体移植物抗肿瘤效应的概念。